기사
Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations /
- 개인저자
- Fiscella, Richard G. ;, Lewis, Charles C. ;, Jensen, Michael K.;
- 수록페이지
- 2069-2073 p.
- 발행일자
- 2007.10.01
- 출판사
- American Society of Health-System Pharmacists
초록
[영문]Purpose. The utilization and refill rates of topical ophthalmic fourth-generation fluoroquinolones among physicians, as well as the associated costs, were studied. Methods. A large data set of retrospective pharmacy prescription claims was obtained from multiple plans, including commercial managed care organizations, Medicaid, and Medicare. The data included the number and cost of all new and refill prescriptions for six months for gatifloxacin 0.3% and moxifloxacin 0.5% by physician specialty. New prescription and refill data were also analyzed from a state Medicaid plan to determine if similar trends existed. Results. Primary care physicians wrote approximately 7,000 (7.7%) gatifloxacin and 84,000 (92.3%) moxifloxacin prescriptions, with pediatricians accounting for 4,000 (5.1%) gatifloxacin and 75,000 (94.9%) moxifloxacin prescriptions. Eye care physicians accounted for a similar amount of prescriptions for each antibiotic during the same period. The total cost of prescriptions for all primary care practitioners was approximately